Ultibro Breezhaler: LABA/LAMA fixed-dose combination inhaler

Novartis has launched Ultibro Breezhaler, a breath-actuated dry powder inhaler containing indacaterol and glycopyrronium bromide, for the maintenance treatment of COPD.

by
Patients should inhale the contents of one Ultibro capsule using the Breezhaler device once daily at the same time each day.
Patients should inhale the contents of one Ultibro capsule using the Breezhaler device once daily at the same time each day.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package